Positive CHMP Opinion For BioMarin's Gene Therapy To Treat Severe Hemophilia A

BioMarin Pharmaceutical Inc. (BMRN) on Friday said it received positive opinion from European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for conditional marketing authorization of its investigational gene therapy, valoctocogene roxaparvovec, for the treatment of adults with severe hemophilia A.

The CHMP based its positive opinion on the totality of data from the valoctocogene roxaparvovec clinical development program, including two-year outcomes from the global GENEr8-1 Phase 3 study, supported by five and four years of follow-up from the 6e13 vg/kg and 4e13 vg/kg dose cohorts respectively, in the ongoing Phase 1/2 dose escalation study, BioMarin said.

The company plans to market the drug under the brand name Roctavian.

Roctavian is the first gene therapy to be recommended for approval in Europe for hemophilia A. A final decision is expected in the third quarter of 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ford Motor Co. is seeking a new trial in a Georgia court after a jury reached a $1.7 billion verdict in a lawsuit against the automotive major regarding a truck rollover accident, The Wall Street Journal reported. In the new court filings, Ford said it was unfairly precluded from providing evidence and thus defending against claims that its trucks were defective. Omnichannel retailer Macy's, Inc. announced Monday plans to hire colleagues for more than 41,000 full- and part-time seasonal positions for the upcoming holiday season. The colleagues will be positioned at its Macy's, Bloomingdale's and Bluemercury stores, supply chain locations and call centers. Seffner, Florida -based Canyon Furniture Co. is recalling ladders sold with bunk bed and hutch sets citing entrapment and strangulation risks, the U.S. Consumer Product Safety Commission said. The about 2,100 units of Canyon Lake and Cottage Colors Bunk Bed and Hutch Sets were sold exclusively at Rooms To Go.
Follow RTT